PCI at non-PCI centres: immediate or rescue?
Danchin
Nicolas
N
Department of Coronary Artery Disease and Intensive Care, Hôpital Européen Georges Pompidou Assistance Publique des Hôpitaux de Paris, Université René Descartes, 75015 Paris, France. Nicolas.danchin@egp.ap-hop-paris-fr
Armstrong
Paul W
PW
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D009203:Myocardial Infarction / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D011994:Recombinant Proteins; C087896:reteplase; D010959:Tissue Plasminogen Activator; D000077284:Abciximab